We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-4.22%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$16.9B
AUM Growth
-$2.13B
(-11%)
Cap. Flow
-$1.02B
Cap. Flow
% of AUM
-6.06%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
1,372
New
74
Increased
459
Reduced
680
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$138M |
| 2 |
NVIDIA
NVDA
|
+$69.6M |
| 3 |
Synaptics
SYNA
|
+$37.7M |
| 4 |
Microchip Technology
MCHP
|
+$29.7M |
| 5 |
Lam Research
LRCX
|
+$24.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$184M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$170M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$169M |
| 4 |
Apple
AAPL
|
+$131M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Financials | 15.03% |
| 3 | Energy | 6.15% |
| 4 | Healthcare | 5.33% |
| 5 | Consumer Discretionary | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Intellia Therapeutics
NTLA
$1.5B
| $6.52M | 0.04% |
89,721
+41,867
| +87% | +$3.55M |
|
302
Wintrust Financial
WTFC
$10.9B
| $6.51M | 0.04% |
70,091
+5,466
| +8% | +$533K |
|
303
CareDx
CDNA
$2.48B
| $6.43M | 0.04% |
173,732
+50,988
| +42% | +$1.99M |
|
304
Texas Pacific Land
TPL
$28B
| $6.42M | 0.04% |
42,714
-5,139
| -11% | -$677K |
|
305
American Tower
AMT
$80.6B
| $6.42M | 0.04% |
25,538
+393
| +2% | +$95.9K |
|
306
Prosperity Bancshares
PB
$9.02B
| $6.41M | 0.04% |
92,337
+9,645
| +12% | +$711K |
|
307
MarketAxess Holdings
MKTX
$5.71B
| $6.4M | 0.04% |
18,806
-908
| -5% | -$329K |
|
308
Abbott
ABT
$185B
| $6.4M | 0.04% |
54,051
-5,384
| -9% | -$667K |
|
309
Lincoln National
LNC
$8.82B
| $6.39M | 0.04% |
97,791
-9,927
| -9% | -$678K |
|
310
iShares Global Clean Energy ETF
ICLN
$2.35B
| $6.38M | 0.04% |
296,575
-4,456
| -1% | -$87.2K |
|
|
WLL
311
DELISTED
Whiting Petroleum Corporation
WLL
| $6.35M | 0.04% |
77,894
-33,665
| -30% | -$2.54M |
|
312
BridgeBio Pharma
BBIO
$15.7B
| $6.33M | 0.04% |
623,202
+477,498
| +328% | +$4.9M |
|
313
Charter Communications
CHTR
$17.2B
| $6.31M | 0.04% |
11,562
+5,093
| +79% | +$2.99M |
|
314
Vir Biotechnology
VIR
$1.5B
| $6.3M | 0.04% |
244,837
+123,896
| +102% | +$3.67M |
|
|
APLS
315
DELISTED
Apellis Pharmaceuticals
APLS
| $6.28M | 0.04% |
123,495
-2,415
| -2% | -$107K |
|
|
PACW
316
DELISTED
PacWest Bancorp
PACW
| $6.27M | 0.04% |
145,394
+1,943
| +1% | +$91.7K |
|
|
JNPR
317
DELISTED
Juniper Networks
JNPR
| $6.25M | 0.04% |
168,199
-22,829
| -12% | -$784K |
|
318
Pinduoduo
PDD
$128B
| $6.22M | 0.04% |
155,183
+84,211
| +119% | +$4.33M |
|
319
Incyte
INCY
$24B
| $6.2M | 0.04% |
78,069
-8,874
| -10% | -$645K |
|
320
Veracyte
VCYT
$3.58B
| $6.2M | 0.04% |
224,763
+90,313
| +67% | +$2.58M |
|
321
Fate Therapeutics
FATE
$291M
| $6.18M | 0.04% |
159,390
+52,122
| +49% | +$2.02M |
|
322
Halozyme
HALO
$9.76B
| $6.14M | 0.04% |
153,996
+1,153
| +0.8% | +$41.1K |
|
323
Cboe Global Markets
CBOE
$31.2B
| $6.12M | 0.04% |
53,524
-2,583
| -5% | -$306K |
|
324
Green Plains
GPRE
$1.17B
| $6.08M | 0.04% |
196,096
+5,707
| +3% | +$179K |
|
325
Arrowhead Research
ARWR
$12.1B
| $6.05M | 0.04% |
131,557
+53,832
| +69% | +$2.67M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Rafferty Asset Management held 1,372 positions worth $16.9B, down 11% from $19B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rafferty Asset Management withdrew a net $1.02B in Q1 2022, closing 155 positions and reducing 680 holdings. Its most notable exit was Xilinx Inc, an estimated $169M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Energy.
Against the trend, Rafferty Asset Management opened a new position in Synaptics worth $33.9M.
- Rafferty Asset Management's largest Q1 2022 buy was Synaptics: 170,061 shares worth $33.9M.
- Rafferty Asset Management added most to Advanced Micro Devices in Q1 2022, an estimated $138M increase.
- Rafferty Asset Management's biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $184M.
- Rafferty Asset Management fully exited Xilinx Inc in Q1 2022, selling an estimated $169M.
- Rafferty Asset Management's ten largest holdings make up 39% of its $16.9B portfolio in Q1 2022.
- Rafferty Asset Management opened 74 new positions and closed 155 in Q1 2022.
- Rafferty Asset Management's portfolio value fell 11% quarter-over-quarter to $16.9B.
Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.